Personalized Medicine: New Insights into Treating Cancer and Multiple Comorbidities
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Therapy and Drug Delivery".
Deadline for manuscript submissions: 31 March 2025 | Viewed by 167
Special Issue Editors
Interests: oxidative stress; laboratory hematology; nanoparticles; stem cells differentiation
Special Issues, Collections and Topics in MDPI journals
Interests: cancer nursing; radiotherapy and cancer; inmmunotherapy and cancer; breast cancer; lung cancer; cancer and diabetes
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Personalized medicine is revolutionizing the way we approach the treatment of cancer, particularly when it coexists with other complex diseases. By tailoring medical care to the unique genetic, environmental, and lifestyle characteristics of each patient, personalized medicine enables healthcare providers to predict which treatments will be most effective, with greater accuracy. This approach is especially crucial in cancer care, where the precise targeting of therapies can significantly improve outcomes while minimizing harmful side effects and drug interactions.
In the context of managing multiple diseases, personalized medicine becomes even more critical. Patients with cancer often face a challenging landscape of coexisting conditions, such as diabetes, hypertension, and cardiovascular diseases. These comorbidities not only complicate treatment decisions but also require a highly coordinated and individualized care plan that can address the intricate interactions between various health conditions and their treatments. By focusing on the distinct profile of each patient, personalized medicine aims to not only enhance the efficacy of cancer therapies but also improve overall quality of life, ensuring that the complexities of managing multiple diseases are effectively addressed.
The simultaneous treatment of cancer and multiple diseases, furthermore, presents significant challenges due to the complex interactions between various health conditions and their respective therapies, underscoring the fact that patients with these overlapping health concerns require a tailored, multidisciplinary approach to care that considers the potential for drug interactions, compounded side effects, and the cumulative impact on their overall health. The variability in disease progression and individual patient responses further complicates management, underscoring the urgent need for ongoing research and innovation. Thus, this Special Issue aims to address these challenges by providing a platform for research that can lead to more effective, personalized treatment strategies for patients with cancer and multiple comorbidities. Our Special Issue seeks to gather cutting-edge research articles and comprehensive reviews that delve into the intersection of cancer treatment and personalized medicine in the context of multiple diseases. We welcome contributions that highlight innovative approaches, successful case studies, and in-depth analyses that can advance the field and lead to better patient care.
Dr. Ioannis Tsamesidis
Dr. Maria Lavdaniti
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer
- quality of life
- autoimmune diseases
- diabetes
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
